Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study
European Stroke Journal · 01.12.2025 · 10 (4) · 1489-1501
DOI: 10.1177/23969873251333282 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Stroke Journal, online erschienen am 01.12.2025. Verfasst von Matteo Foschi und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Hauptthemen laut MEDLINE: Dual Anti-Platelet Therapy, Ischemic Attack, Transient, Ischemic Stroke, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Patients with ischemic stroke or transient ischemic attack (TIA) and cancer face unique risks of recurrent ischemic events and bleeding. It is unclear whether this increased risk is present even in patients with minor ischemic stroke or transient ischemic attack (TIA) receiving dual antiplatelet therapy (DAPT). This study aimed to evaluate the impact of cancer on the short-term outcomes after DAPT in patients with non-cardioembolic minor ischemic stroke or high-risk TIA. Patients and methods: This was a secondary analysis of the prospective multicentric READAPT study (NCT05476081), including patients with non-cardioembolic minor ischemic stroke (NIHSS ⩽ 5) or high-risk TIA (ABCD2 ⩾4) who initiated DAPT within 48 h of symptom onset. The primary effectiveness outcome was the 90-day risk of new ischemic stroke or other vascular events (TIA, myocardial infarction, death due to vascular causes). Secondary outcomes included 90-day mRS score distribution and all-cause mortality. The primary safety outcome was the 90-day risk of any bleeding, with secondary safety outcomes including 24-h hemorrhagic transformation. We used Inverse Probability Weighting to compare outcomes between patients with and without cancer.
Results
From 2278 patients in the READAPT study cohort, we included 1561 patients (mean age 70.3 ± 11.7 years; 65.4% males), of whom 206 (13.2%) had cancer, categorized as either active (27.7%) or in remission (72.3%). After weighting, overall cancer patients had a higher risk of 90-day new ischemic stroke or other vascular events (weighted HR 1.78, 95% CI 1.20–2.63, p = 0.004) and worse 90-day mRS score distribution (OR 1.24, 95% CI 1.10–1.41, p < 0.001) compared to patients without cancer. The 90-day risk of bleeding did not differ between cancer and no-cancer groups overall. When analyzing cancer subgroups, patients with active cancer had significantly higher risk of 90-day ischemic stroke or other vascular (weighted HR 2.75, 95% CI 1.70–4.45, p < 0.001) and any bleeding (weighted HR 2.51, 95% CI 1.27–4.97, p = 0.008) events compared to no-cancer patients. In contrast, patients with cancer in remission had comparable risks to those without cancer. Furthermore, hematological malignancies were associated with a substantially higher risk of 90-day new ischemic stroke or other vascular events compared to solid tumors (weighted HR 8.15, 95% CI 5.06–13.14, p < 0.001).
Conclusions
Patients with minor ischemic stroke or high-risk TIA and active cancer have increased risk of ischemic and bleeding events after DAPT. Conversely, patients with cancer in remission have similar outcomes compared to those with no cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
- Department of Brain Sciences, Imperial College London, London, UK; Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
- Stroke Unit, Maurizio Bufalini Hospital, Cesena, Italy.
- Department of Neurology, Santa Corona Hospital, Pietra Ligure, Italy.
- Department of Neurology, Città di Castello Hospital, Città di Castello, Italy.
- Department of Neurology, ASST Ospedale Maggiore di Crema, Crema, Italy.
ORCID-Profile: Matteo Foschi, Federico De Santis, Lucio D'Anna, Michele Romoli, Valentina Saia, Marialuisa Zedde, Anna Maria Cavallini, Marina Mannino, Maurizio Paciaroni, Maria Giulia Mosconi, Rossana Tassi, Enzo Sanzaro, Giovanna Viticchi, Federica Nicoletta Sepe
Zitieren
APA
Foschi, M., De Santis, F., D'Anna, L., Romoli, M., Tassinari, T., Saia, V., Cenciarelli, S., Bedetti, C., Padiglioni, C., Censori, B., Puglisi, V., Vinciguerra, L., Guarino, M., Barone, V., Zedde, M., Grisendi, I., Diomedi, M., Bagnato, M. R., Petruzzellis, M., …, & Di Blasio, F. (2025). Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study. European Stroke Journal, 10(4), 1489-1501. https://doi.org/10.1177/23969873251333282
Vancouver
Foschi M, De Santis F, D'Anna L, Romoli M, Tassinari T, Saia V, et al. Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study. European Stroke Journal. 2025;10(4):1489-1501. doi:10.1177/23969873251333282
BibTeX
@article{Foschi2025,
author = {Foschi, Matteo and De Santis, Federico and D'Anna, Lucio and Romoli, Michele and Tassinari, Tiziana and Saia, Valentina and Cenciarelli, Silvia and Bedetti, Chiara and Padiglioni, Chiara and Censori, Bruno and Puglisi, Valentina and Vinciguerra, Luisa and Guarino, Maria and Barone, Valentina and Zedde, Marialuisa and Grisendi, Ilaria and Diomedi, Marina and Bagnato, Maria Rosaria and Petruzzellis, Marco and Mezzapesa, Domenico Maria and Inchingolo, Vincenzo and Cappellari, Manuel and Zivelonghi, Cecilia and Candelaresi, Paolo and Andreone, Vincenzo and Rinaldi, Giuseppe and Bavaro, Alessandra and Cavallini, Anna Maria and Piscaglia, Maria Grazia and Terruso, Valeria and Mannino, Marina and Pezzini, Alessandro and Frisullo, Giovanni and Muscia, Francesco and Paciaroni, Maurizio and Mosconi, Maria Giulia and Zini, Andrea and Leone, Ruggiero and Palmieri, Carmela and Cupini, Letizia Maria and Marcon, Michela and Tassi, Rossana and Sanzaro, Enzo and Papiri, Giulio and Viticchi, Giovanna and Orsucci, Daniele and Falcou, Anne and Diamanti, Susanna and Tarletti, Roberto and Nencini, Patrizia and Rota, Eugenia and Sepe, Federica Nicoletta and Ferrandi, Delfina and Caputi, Luigi and Volpi, Gino and Laspada, Salvatore and Beccia, Mario and Rinaldi, Claudia and Mastrangelo, Vincenzo and Di Blasio, Francesco},
title = {Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study},
journal = {European Stroke Journal},
year = {2025},
volume = {10},
number = {4},
pages = {1489--1501},
doi = {10.1177/23969873251333282}
}
EUVIMED